Stockscreener 앱 받기
3.90
3.23%
-0.13
시간 외 거래:
4.00
0.10
+2.56%
전일 마감가:
$4.03
열려 있는:
$4
하루 거래량:
31,569
Relative Volume:
0.58
시가총액:
$7.83M
수익:
순이익/손실:
$-17.10M
주가수익비율:
-0.0165
EPS:
-236.7281
순현금흐름:
$-15.92M
1주 성능:
-13.33%
1개월 성능:
-43.48%
6개월 성능:
-40.73%
1년 성능:
-71.20%
1일 변동 폭
$3.90
$4.11
1주일 범위
$3.90
$5.31
52주 변동 폭
$3.25
$23.50
Quoin Pharmaceuticals Ltd Adr Stock (QNRX) Company Profile
명칭
Quoin Pharmaceuticals Ltd Adr
전화
97299741444
주소
23 HATA'AS STREET, KFAR SABA
Compare QNRX vs VRTX, MRNA, REGN, ARGX, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
QNRX
Quoin Pharmaceuticals Ltd Adr
|
3.90 | 7.83M | 0 | -17.10M | -15.92M | -236.73 |
VRTX
Vertex Pharmaceuticals Inc
|
499.74 | 126.66B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
218.01 | 87.04B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
790.74 | 81.41B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
819.14 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
369.06 | 41.75B | 5.76B | 514.49M | 1.10B | 4.4813 |
Quoin Pharmaceuticals Ltd Adr Stock (QNRX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-10-12 | 개시 | BTIG Research | Buy |
| 2026-09-23 | 개시 | Lake Street | Buy |
Quoin Pharmaceuticals Ltd Adr 주식(QNRX)의 최신 뉴스
Two parties report a passive stake in Quoin Pharmaceuticals (QNRX), covering 211,538 depositary shares. - Stock Titan
Quoin Pharmaceuticals (QNRX) Climbs 3.51% to $4.72 as Shares Sit Near Mid-Range LevelsUpthrust Pattern - https://www.dars.gov.et/
Quoin registers 9.37M depositary shares for resale - Stock Titan
Shareholders in Quoin (QNRX) face vote on letting warrant holders own more and gain extra voting power - Stock Titan
Potential dilution looms as Quoin (NASDAQ: QNRX) registers ADS resales tied to warrant exercises - stocktitan.net
A doctor met a critically ill baby in the ICU, then adopted her - Stock Titan
Tuesday’s insider buys and sells: Quoin Pharma executives lead purchases - Investing.com India
Tuesday’s insider buys and sells: Quoin Pharma executives lead purchases - Investing.com
Quoin Pharmaceuticals CEO Michael Myers buys $99,991 ADSs By Investing.com - Investing.com UK
Tuesday’s insider buys and sells: Quoin Pharma executives lead purchases By Investing.com - Investing.com Australia
Quoin Pharmaceuticals CEO Michael Myers buys $99,991 ADSs - Investing.com
Quoin Pharmaceuticals director Culverwell buys $29,992 in ADSs - Investing.com
Quoin Pharmaceuticals CFO Lawlor buys $49,990 in company stock - Investing.com
Quoin Pharmaceuticals CEO Michael Myers buys $99,991 ADSs - Investing.com India
Quoin Pharmaceuticals COO Denise Carter buys $99,991 in ADSs By Investing.com - Investing.com UK
Quoin Pharmaceuticals director Culverwell buys $29,992 in ADSs By Investing.com - Investing.com India
Quoin Pharmaceuticals CFO Lawlor buys $49,990 in company stock - Investing.com India
Quoin Pharmaceuticals (QNRX) CEO buys more ADSs with attached warrants - Stock Titan
Quoin Pharmaceuticals (QNRX) insider adds ADSs and warrants in private placement - Stock Titan
Dow Gains 100 Points; Chicago PMI Falls In August - Sahm
Quoin Pharmaceuticals Stock Surges Friday: What's Happening? - Sahm
Why Elastic Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving Premarket - Sahm
Dow Gains 100 Points; Chicago PMI Falls In August - Benzinga
Quoin Pharmaceuticals raises $30.8M in private placement - Investing.com
Why Elastic Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving Premarket - Benzinga
Quoin Pharmaceuticals Announces Private Placement Financing of Up to $50.0 Million - Barchart.com
Quoin Pharmaceuticals Announces Up to $50 Million Private Placement Financing to Support QRX003 Development - Quiver Quantitative
Quoin Pharmaceuticals Secures Up to $50 Million to Advance Rare Disease Pipeline - citybiz
Quoin Pharma (QNRX) swaps $177,849 debt into director ADSs - Stock Titan
Quoin Pharma (NASDAQ: QNRX) director takes 31K ADSs for interest - Stock Titan
Dow rises 100 points as Chicago PMI misses estimates in August - scanx.trade
Quoin (QNRX) Update: Rises 7.12% to $5.57 in the Latest Reading - careplusvn.com
Quoin (QNRX) Update: Rises 7.12% to $5.57 in the Latest Reading - siam.in
Quoin (QNRX) Update: Rises 7.12% to $5.57 in the Latest Reading; $5.29 and $5.85 Define the Nearby Reference Levels in the Latest ReadingVolatility Smirk - dars.gov.et
Quoin Pharma (NASDAQ: QNRX) lifts board pay ceiling to $250K plus options - Stock Titan
Quoin Pharmaceuticals | 10-Q: Q2 2026 Earnings Report - Moomoo
Quoin Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2026 Financial Results - Barchart.com
Quoin Pharmaceuticals to Announce Corporate Update and Second Quarter 2026 Financial Results on Friday, August 14, 2026 - Barchart.com
Cash flow from investing activities of Quoin Pharmaceuticals. Ltd Sponsored ADR – LS:A41BEM - TradingView
Cash flow from financing activities of Quoin Pharmaceuticals. Ltd Sponsored ADR – LS:A41BEM - TradingView
Book value per share of Quoin Pharmaceuticals. Ltd Sponsored ADR – LS:A41BEM - TradingView
Average basic shares outstanding of Quoin Pharmaceuticals. Ltd Sponsored ADR – LSX:A41BEM - TradingView
Quoin Pharmaceuticals (QNRX) Slightly Declines as Stock Tests Support Near $3.95Bollinger Band - careplusvn.com
Quoin Pharmaceuticals (QNRX) Slightly Declines as Stock Tests Support Near $3.95MESA MA - dars.gov.et
Insider Traders Lose US$65k As Quoin Pharmaceuticals Drops - Sahm
Price to earnings forward of Quoin Pharmaceuticals. Ltd Sponsored ADR – FWB:2EB0 - TradingView
Price to book forward of Quoin Pharmaceuticals. Ltd Sponsored ADR – FWB:2EB0 - TradingView
Enterprise value to EBIT forward of Quoin Pharmaceuticals. Ltd Sponsored ADR – FWB:2EB0 - TradingView
QNRX Q1 2026 Earnings: Narrower-than-Expected Loss Drives Share Price UptickDividend Increase Stocks - careplusvn.com
Quoin Pharmaceuticals Receives FDA IND Clearance to Initiate Phase 2 Study of QRX003 in Peeling Skin Syndrome - Sahm
Quoin Pharmaceuticals Ltd Adr (QNRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Quoin Pharmaceuticals Ltd Adr 주식 (QNRX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Myers Michael | Chief Executive Officer |
Aug 31 '26 |
Buy |
4.88 |
20,490 |
99,991 |
37,713 |
| Lawlor Sally Bridget | Chief Financial Officer |
Aug 31 '26 |
Buy |
4.88 |
10,244 |
49,991 |
10,684 |
| Culverwell Anthony James | Director |
Aug 31 '26 |
Buy |
4.88 |
6,146 |
29,992 |
40,364 |
| LANGER DENNIS | Director |
Oct 14 '25 |
Buy |
8.49 |
15,152 |
128,640 |
15,153 |
4.22%
자본화:
|
볼륨(24시간):